Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Preterm Preeclampsia
NCT06452498Phase 3Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2025
- Primary completion
- Mar 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs) in preeclampsia, sponsored by Amsterdam University Medical Center. Started Sep 2025; status: recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT06452498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06452498.